| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Urology [B. L. L., N. L. B.] and Oncology [N. L. B.], University of Miami School of Medicine, Miami, Florida 33101
Human seminal plasma (SP) has been known to contain both growth-inhibitory and -stimulatory factors. We attempted to identify a factor that inhibited DNA synthesis in some metastatic prostate cancer cell lines. The SP factor was sensitive to digestion by trypsin, but its activity increased after boiling or dialysis against 1 M acetic acid, by 3- to 4-fold. The SP factor was partially purified using a cation-exchange resin. Apparent molecular mass determination by sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed it to be a Mr 25,000 protein, and Mr 13,000 after reduction. This protein strongly inhibited DNA synthesis in two metastatic androgen-independent human prostatic carcinoma cell lines (PC3 and DU145) and the Dunning R3327G rat prostatic adenocarcinoma. It was ineffective on androgen-dependent LNCaP cells. The proliferation-inhibiting activity of this SP protein was specifically and completely abolished by a neutralizing anti-transforming growth factor ß (TGF-ß) antiserum. Furthermore, immunoblot analysis using the anti-TGF-ß antiserum showed the similarity of this protein to TGF-ß. The maximum concentration of this protein in SP was 165 ± 11.7 ng/ml (mean ± SD), of which only one-fourth may be present in active form under normal conditions. Identification of a TGF-ß-like protein in SP might also explain the variety of growth and immune modulation properties of human SP.
1 Funded in part by the Weeks Endowment Fund, Department of Urology, University of Miami.
2 To whom requests for reprints should be addressed, at Department of Urology (M-800), University of Miami School of Medicine, P. O. Box 016960, Miami, FL 33101.
Received 7/10/92. Accepted 8/31/92.
This article has been cited by other articles:
![]() |
J. A. Politch, L. Tucker, F. P. Bowman, and D. J. Anderson Concentrations and significance of cytokines and other immunologic factors in semen of healthy fertile men Hum. Reprod., November 1, 2007; 22(11): 2928 - 2935. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Loras, F. Vetele, A. E. Malki, J. Rollet, J.-C. Soufir, and M. Benahmed Seminal transforming growth factor-ß in normal and infertile men Hum. Reprod., June 1, 1999; 14(6): 1534 - 1539. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |